Medical Devices, Medicines & Lab Supplies

Own manufacturers of tangible healthcare products, spanning medical devices, established medicines and laboratory supplies rather than insurers or care-delivery platforms. Danaher's recent results provide a fresh checkpoint for laboratory and bioprocessing demand, while the technology selloff strengthens the case for diversifying revenue exposure away from AI spending. Device-heavy holdings distinguish this basket from North's drug-development and life-science portfolios, although reimbursement pressure and research-budget weakness remain risks. Catalysts: - 2026-10-21 DHR: Danaher reports third-quarter 2026 results (https://www.stocktitan.net/news/2026-10-21/) Launch basket (equal weight): JNJ, MDT, TMO, ABBV, AMGN, DHR, ABT, GEHC, BSX, SYK Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.